luay alsaoor

Medical Oncologist at Azadi Teaching Hospital / Duhok

[Mustafa Özdoğan, MD @ozdogan_md]

Gastric Cancer: A Comprehensive Update (JAMA, 2026)

Gastric cancer management has decisively shifted from anatomy-based staging to molecularly driven precision medicine.

Reference:
Patel AK, Sethi NS, Park H. Gastric Cancer: A Review.
JAMA. Published online January 7, 2026.
https://t.co/kJ9MUMDIsi

#GastricCancer #PrecisionOncology #GIOncology #ClinicalPractice

[Dr Rishabh Jain @DrRishabhOnco]

🌟 NorthStar #ESMO25
Adding local consolidative therapy (LCT) to osimertinib in EGFR+ metastatic NSCLC boosted outcomes 💥

📊 mPFS: 25.3 vs 17.5 mo (HR 0.66, p = 0.025)
💪 Benefit in both ≤3 & >3 mets
🧬 Ex19del 39.8 vs 22.4 mo | L858R 19.0 vs 11.0 mo
🩺 No added toxicity

✅ Takeaway: Osimertinib + LCT = longer control, same safety

#OncoTwitter #MedTwitter #LungCancer #ESMO25 @myESMO @esmo_open @OncoAlert

[Oncology Brothers @OncBrothers]

Day 1 #ESMO25 Highlights:

Breast Ca:
1. #POSITIVE 🤰 outcomes

2. #monarchE HR+ Adj Abema

3. #NATALEE HR+ Adj Ribo

Lung Ca:
4. #NorthStar Local Rx in mEGFR

5. #FLAURA2 Chemo + Osi in mEGFR

6. #SOHO01 & #BeamionLung01 HER2+ NSCLC

1/12

#OncTwitter @myESMO @OncUpdates

[luay alsaoor @luayalsaoor]

Gemcitabine and Docetaxel vs Bacillus Calmette Guérin for Bladder Cancer https://t.co/seO2ZUP75r via @JAMANetworkOpen part of @JAMANetwork

[luay alsaoor @luayalsaoor]

https://t.co/cpjk6kpeMW https://t.co/0LwpfI3oMC

[luay alsaoor @luayalsaoor]

Immune-Based Advances in Gastric, Esophageal, and Gastroesophageal Junction Cancers https://t.co/HorMhI7iqN via @ReachMD

[luay alsaoor @luayalsaoor]

LUNG CANCER (Bronchogenic Carcinoma) - ppt download https://t.co/Vgwjf4UkoM

[luay alsaoor @luayalsaoor]

Graves’ hyperthyroidism and anti-thyroid drugs By 蔡文欽. - ppt download https://t.co/BzqXLk6Mj3

[Dipesh Uprety MD FACP @DipeshUpretyMD]

Chemo-IO vs IO in patients with stage IV NSCLC: an FDA pooled analysis from 12 studies (n=9084): No difference in OS between chemo-IO and IO arm. Older adults (>=75 years) may have better OS and PFS with IO. Limitation of the study: Exploratory #LCSM #ASCO22 @OncoAlert

[luay alsaoor @luayalsaoor]

Pancreatic Cancer: Expert Insights for Optimal Treatment - ppt download https://t.co/dGZy9aCdWn

[luay alsaoor @luayalsaoor]

Pancreatic Cancer: Expert Insights for Optimal Treatment - ppt download https://t.co/aWd64aVd5g

[luay alsaoor @luayalsaoor]

Molecular Predictors in Clinical Decision Making for Colon Cancer - ppt download https://t.co/ifo6d44RZ3

[luay alsaoor @luayalsaoor]

27 Sep – 1 Oct 2013 | Amsterdam, Netherlands ESMO-ECCO Supported by Eli Lilly and Company. Eli Lilly and Company has not influenced the content of this. - ppt download https://t.co/EtB84UrK8J

[luay alsaoor @luayalsaoor]

Overview of Targeted Therapies for Esophageal and Gastric Cancers Johanna Bendell, MD Director, GI Oncology Research Associate Director, Drug Development. - ppt download https://t.co/w3rUNUNqcp

[luay alsaoor @luayalsaoor]

The role of the Oncotype DX® assay in breast cancer management - ppt download https://t.co/kGBZRm3hxY

[luay alsaoor @luayalsaoor]

The role of the Oncotype DX® assay in breast cancer management - ppt download https://t.co/XrlqI6vANV

[luay alsaoor @luayalsaoor]

The role of the Oncotype DX® assay in breast cancer management - ppt download https://t.co/rNL27BsNLo

[luay alsaoor @luayalsaoor]

Adjuvant Metronomic Capecitabine for Locoregionally Advanced Nasopharyngeal Carcinoma - The ASCO Post https://t.co/1TKGdRhWo1

[luay alsaoor @luayalsaoor]

Fiber Presented by Janice Hermann, PhD, RD/LD - ppt video online download https://t.co/EeaEj9o8AG

[Daniel Catenacci @DocCatenacci]

I agree @pashtoonkasi
I have a number of patients with upper GI cancers w MSI high tumors who after only 1 year of AntiPD-1 tx (then stop) with CR are now on surveillance for several years and essentially cured. Would not do surgery in somebody that fits this story line.